GQG Partners is a funds management business that has recorded strong earnings growth over the past year, with EPS rising from US$0.095 to US$0.14. Since 2023 it has grown its funds under management from US$106 billion to US$143 billion, while return on equity sits near 80 per cent.

The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.

I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.

There’s an old saying that in a gold rush, those who make the money are the ones selling the shovels; and mining service companies have indeed proven to be shrewd investments historically. XRF Scientific holds a strong niche in sample preparation equipment and consumables used in X-ray fluorescence (XRF) and X-ray diffraction (XRD) analysis, which are essential in determining the quality and purity of materials.

Pro Medicus (ASX: PME) is an Australian company that develops medical imaging software under its Visage product range. Leading medical institutions including NYU Langone, UCSF, and Mass General Brigham have publicly or semi-publicly praised the platform—often via PME-issued press releases or interviews.

Let me preface this article by admitting my bias: I’m a big fan of Games Workshop. While I’ve never personally gotten into the tabletop game, I’m deeply drawn to the incredible sci-fi and fantasy universes the company has built.

Despite its somewhat cringe worthy name—ironically the kind Peter Lynch often sought in his hunt for undervaluation—Boss Energy has emerged as a key player in Australia's uranium sector. With macroeconomic trends pointing towards a global pivot away from fossil fuels over coming decades, uranium is well-positioned to benefit.

As of 31 July 2024, Suncorp completed the sale of its banking division to ANZ, marking a significant strategic shift to become a pure-play insurance company. Almost a year into this transformation, it's worth reviewing how the business is shaping up ahead of the next reporting season.

Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed Momentum Vita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and supplements across the Asia-Pacific region. Founded in 1947, the company boasts strong brand recognition through its labels such as VitaHealth, Herbs of Gold, VitaScience, and VitaLife, offering over 350 premium healthcare and pharmaceutical products.